MapLight Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MapLight Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($29.42M) | Dec 4, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($29.85M) | Dec 4, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($22.34M) | Dec 4, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($19.02M) | Dec 4, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($18.40M) | Dec 4, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($18.94M) | Dec 4, 2025 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($31.50M) | Dec 4, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($20.89M) | Dec 4, 2025 |